THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (Nasdaq:RPRX) today announced the completion of a public offering of 2,610,000 shares of its common stock at a public offering price of $13.75 per share. The net proceeds to the company from the sale of shares of its common stock in this offering were approximately $33.0 million. CIBC World Markets Corp. acted as sole book-running manager in this offering. Punk, Ziegel & Company acted as co-lead manager. ThinkEquity Partners LLC acted as co-manager.
